congenital hyperinsulinism
MeSH: D044903ORPHA: 6571 Treatment Available
Overview
genetic disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| diazoxide Orphan | Oral suspension, 50mg/mL | FDA Approved, EMA Approved | 6 | 14d |
Classification & Codes
MeSH Code
D044903Orphanet Code
ORPHA:657congenital hyperinsulinism
| MeSH | D044903 |
| Orphanet | ORPHA:657 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO